Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04374968 · ClinicalTrials.gov registry record · NA

Use of Blood Flow Restriction Therapy Following ACL Tear

A NA study of Knee Injuries and Anterior Cruciate Ligament Tear, sponsored by Henry Ford Health System.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04374968: Completed NA study of Knee Injuries and Anterior Cruciate Ligament Tear, sponsored by Henry Ford Health System.

NCT04374968 is a NA study of Knee Injuries and Anterior Cruciate Ligament Tear that has completed, run by Henry Ford Health System. The registered enrollment target is 50 participants, below the 175-participant average among 14 other Knee Injuries trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04374968, a NA study of Knee Injuries and Anterior Cruciate Ligament Tear, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Evaluating the use of peri-operative blood flow restriction therapy surrounding anterior cruciate ligament tear

Primary Outcome

Quadriceps strength via handheld dynamometer

Interventions

  • DEVICE Blood flood restriction cuff

Study Locations (1)

Michigan

  • Henry Ford Hospital - West Bloomfield

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2020-07-28
Est. Completion 2022-05-01
Phase NA
Henry Ford Health System

234 total trials

What the finished NCT04374968 record still lists

NCT04374968 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 175-participant average among 14 other Knee Injuries trials with a reported enrollment target (71% lower).

The record links to 3 conditions, with Knee Injuries appearing as the primary indexed condition, and to 1 intervention - of which Blood flood restriction cuff is the first listed.

NCT04374968 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT04374968 about?

NCT04374968 is a clinical study titled "Use of Blood Flow Restriction Therapy Following ACL Tear". Evaluating the use of peri-operative blood flow restriction therapy surrounding anterior cruciate ligament tear

What is the current status of trial NCT04374968?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-07-28. Estimated completion is 2022-05-01.

What conditions does trial NCT04374968 study?

This clinical trial studies the following conditions: Knee Injuries, Anterior Cruciate Ligament Tear, Sport Injury.

What interventions are being tested in trial NCT04374968?

The interventions under investigation include: Blood flood restriction cuff (DEVICE).

Who is sponsoring clinical trial NCT04374968?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04374968 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04374968's enrollment target sits among peer trials

50 8th of 14 higher than 5 of 14 other Knee Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Knee Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04374968, the US trial registry maintained by the National Library of Medicine. NCT04374968 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.